Back to
Russell Investments Group, Ltd.
EGRX26 quarters
Position history for
Russell Investments Group, Ltd.'s holdings in EAGLE PHARMACEUTICALS INC
No. Russell Investments Group exited its EGRX (Eagle Pharmaceuticals) position in Q1 2025. Its Q4 2024 13F listed 3,411 shares worth $1,706. Russell Investments Group already held EGRX in its Q4 2018 13F, the earliest on record, and held it in 25 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$576,000
Total Shares Change
-14,307
Quarter-by-Quarter History
Other major holders of EGRX: Janus Henderson Group Ltd.